LianBio Announces Wind Down Of Operations, Workforce Reduction; Stock Up In Pre-Market
The cross-border biotechnology company, LianBio (LIAN), Tuesday announced that its board has decided to commence wind down of operations, including selling of remaining pipeline assets, delisting American Depository Shares or ADSs from the Nasdaq market, deregistering under the SEC Act, and reducing the workforce.
Source: rttnews.com